FLOW KARYOTYPING: OPTIMIZATION AND CLINICAL EVALUATION

流式核型分析:优化和临床评估

基本信息

  • 批准号:
    3314661
  • 负责人:
  • 金额:
    $ 53.46万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1991
  • 资助国家:
    美国
  • 起止时间:
    1991-07-01 至 1994-11-30
  • 项目状态:
    已结题

项目摘要

The overall objective of this project is to develop and evaluate improved analytical cytologic techniques for prenatal detection of disease-linked cytogenetic abnormalities. Emphasis will be on a) improving the speed and sensitivity with which the loss or gain of chromosomal DNA can be detected and quantified during analysis of metaphase chromosomes, b) detection of common cytogenetic abnormalities in interphase cells and c) developing techniques for cytogenetic analysis using fetal cells isolated from maternal blood. These objectives will be pursued by: 1) Applying bivariate flow karyotyping to quantification of the extent of chromosome deletions and duplications as small as 1 Mb. Effort during this project period will be devoted to further increasing the sensitivity of the technique and applying it in a series of collaborative studies to characterize subtle structural aberrations of clinical or molecular biological importance. 2) Optimizing fluorescence in situ hybridization with chromosome specific probes for reliable detection and characterization of numerical aberrations involving chromosomes 21, 18, 13, x and y; segmental duplications (initially 21q22.3 for Down syndrome) and deletions (initially 15q11-13 for Prader-Willi syndrome) in metaphase spreads and in interphase nuclei. 3) Developing chromosome-specific probes to support the fluorescence hybridization studies. Whole-chromosome DNA and ssRNA probes depleted in repetitive sequences will be generated from chromosome-specific cosmid libraries. Composite probes for 21q22.3, 15q11-13 and elsewhere will be generated by starting with "seed" probes already mapped to these regions and "walking" outward in chromosome-specific cosmid libraries to expand the regions covered by the composite probes. 4) Continuing efforts to isolate fetal cells from maternal blood for interphase cytogenetic analysis. Specific projects include: a) determination of the gestational age within the first trimester at which the fetal cells are present at highest frequency in maternal blood,b)determination of the origin of the fetal cells (e.g. leukocytes or cytotrophoblasts) and c) development of procedures for enrichment of the fetal cells.
这个项目的总体目标是开发和评价改进的

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JOE W. GRAY其他文献

JOE W. GRAY的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JOE W. GRAY', 18)}}的其他基金

Administrative Core
行政核心
  • 批准号:
    10166784
  • 财政年份:
    2020
  • 资助金额:
    $ 53.46万
  • 项目类别:
Understanding the Impact of Microscale and Nanoscale Heterogeneity and Resistance
了解微米级和纳米级异质性和阻力的影响
  • 批准号:
    10166790
  • 财政年份:
    2020
  • 资助金额:
    $ 53.46万
  • 项目类别:
Imaging Management and Analysis Core
影像管理和分析核心
  • 批准号:
    10166786
  • 财政年份:
    2020
  • 资助金额:
    $ 53.46万
  • 项目类别:
Omic and Multidimensional Spatial Atlas of Metastatic Breast and Prostate Cancers
转移性乳腺癌和前列腺癌的组学和多维空间图谱
  • 批准号:
    9788351
  • 财政年份:
    2018
  • 资助金额:
    $ 53.46万
  • 项目类别:
Omic and Multidimensional Spatial Atlas of Metastatic Breast and Prostate Cancers
转移性乳腺癌和前列腺癌的组学和多维空间图谱
  • 批准号:
    10005913
  • 财政年份:
    2018
  • 资助金额:
    $ 53.46万
  • 项目类别:
Omic and Multidimensional Spatial Atlas of Metastatic Breast and Prostate Cancers
转移性乳腺癌和前列腺癌的组学和多维空间图谱
  • 批准号:
    10471933
  • 财政年份:
    2018
  • 资助金额:
    $ 53.46万
  • 项目类别:
Molecular, Cellular, and Tissue Characterization Unit
分子、细胞和组织表征单元
  • 批准号:
    10471935
  • 财政年份:
    2018
  • 资助金额:
    $ 53.46万
  • 项目类别:
Molecular, Cellular, and Tissue Characterization Unit
分子、细胞和组织表征单元
  • 批准号:
    10005916
  • 财政年份:
    2018
  • 资助金额:
    $ 53.46万
  • 项目类别:
Molecular, Cellular, and Tissue Characterization Unit
分子、细胞和组织表征单元
  • 批准号:
    10246896
  • 财政年份:
    2018
  • 资助金额:
    $ 53.46万
  • 项目类别:
Omic and Multidimensional Spatial Atlas of Metastatic Breast and Prostate Cancers
转移性乳腺癌和前列腺癌的组学和多维空间图谱
  • 批准号:
    10246894
  • 财政年份:
    2018
  • 资助金额:
    $ 53.46万
  • 项目类别:

相似海外基金

Prader-Willi syndrome (PWS) gene-domain and AAV miniaturization for gene therapy
Prader-Willi 综合征 (PWS) 基因域和 AAV 小型化用于基因治疗
  • 批准号:
    10593218
  • 财政年份:
    2023
  • 资助金额:
    $ 53.46万
  • 项目类别:
Exploration of the role of CART/GPR160 in metabolism in the setting of Magel2 deficiency: Implications for Prader Willi Syndrome
探索 Magel2 缺陷情况下 CART/GPR160 在代谢中的作用:对普瑞德威利综合征的影响
  • 批准号:
    10642678
  • 财政年份:
    2022
  • 资助金额:
    $ 53.46万
  • 项目类别:
Exploration of the role of CART/GPR160 in metabolism in the setting of Magel2 deficiency: Implications for Prader Willi Syndrome
探索 Magel2 缺陷情况下 CART/GPR160 在代谢中的作用:对普瑞德威利综合征的影响
  • 批准号:
    10353236
  • 财政年份:
    2022
  • 资助金额:
    $ 53.46万
  • 项目类别:
The role and function of nurses on transitional care for Prader-Willi Syndrome in oral health care
护士在口腔保健中普瑞德威利综合征过渡护理中的作用和作用
  • 批准号:
    21K10844
  • 财政年份:
    2021
  • 资助金额:
    $ 53.46万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Remodelling of cellular RNA Metabolism during Prader-Willi syndrome
普瑞德-威利综合征期间细胞 RNA 代谢的重塑
  • 批准号:
    2605096
  • 财政年份:
    2021
  • 资助金额:
    $ 53.46万
  • 项目类别:
    Studentship
Epigenome editing of the Prader-Willi syndrome imprinted domain with CRISPR/Cas9
使用 CRISPR/Cas9 对 Prader-Willi 综合征印迹域进行表观基因组编辑
  • 批准号:
    10156474
  • 财政年份:
    2021
  • 资助金额:
    $ 53.46万
  • 项目类别:
Epigenome editing of the Prader-Willi syndrome imprinted domain with CRISPR/Cas9
使用 CRISPR/Cas9 对 Prader-Willi 综合征印迹域进行表观基因组编辑
  • 批准号:
    10410369
  • 财政年份:
    2021
  • 资助金额:
    $ 53.46万
  • 项目类别:
Epigenome editing of the Prader-Willi syndrome imprinted domain with CRISPR/Cas9
使用 CRISPR/Cas9 对 Prader-Willi 综合征印迹域进行表观基因组编辑
  • 批准号:
    10550159
  • 财政年份:
    2021
  • 资助金额:
    $ 53.46万
  • 项目类别:
Molecular analysis of Prader-Willi syndrome by model mice
模型小鼠普瑞德-威利综合征的分子分析
  • 批准号:
    21K07848
  • 财政年份:
    2021
  • 资助金额:
    $ 53.46万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular underpinnings of Prader-Willi syndrome
普瑞德威利综合征的分子基础
  • 批准号:
    10013261
  • 财政年份:
    2019
  • 资助金额:
    $ 53.46万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了